In October 1986, a historic summit meeting was held at Reykjavik, Iceland, between the United States, under the leadership of President Ronald Reagan, and the Soviet Union, under the leadership of President Mikhail Gorbachev. What began as a summit with an agenda of limited reduction of nuclear weapons and human rights quickly transformed into a discussion by the two leaders advocating for elimination of all nuclear weapons. The prospect of a world without nuclear weapons had never before been held at such a high level and has never been held since. These negotiations were truly historic and in many ways groundbreaking in helping to end the Cold War.

Reykjavik, a one-act play, written by Richard Rhodes, is a dialogue taken from the actual transcripts of the negotiations between the two presidents. Rhodes is the author or editor of twenty-four works of history, memoir, and fiction, including The Making of the Atomic Bomb, which won a Pulitzer Prize, a National Book Award, and a National Book Critics Circle Award. A past visiting scholar at MIT and Harvard University, he is presently an associate of the Stanford Center for International Security and Cooperation. 

The play runs for seventy-five minutes and will be followed by a question-and-answer session on May 8 with Richard Rhodes and on May 9 with a panel of nuclear security experts led by Charles Ferguson, president of the Federation of American Scientists.

This program is co-sponsored by the Federation of American Scientists, the Fund for Peace Initiatives, the Center for International Security and Cooperation, the Bowen H. McCoy Family Center for Ethics in Society, and Stanford Continuing Studies.

For additional information on the series, please visit the Stanford Ethics and War series website. 

For additional information on the series, please visit the Stanford Ethics and War series website. 

The book The Soviet Biological Weapons Program: A History by Milton Leitenberg and Raymond A. Zilinskas is scheduled to be published on May 14, 2012 by Harvard University Press. This book describes and analyzes in detail the Soviet biological warfare (BW) program, from its inception in 1928 to likely termination in 1992. The two most vexing questions that the authors attempt to answer are; in the final analysis, what were the Soviet BW program’s accomplishments? Second, might Soviet accomplishments related to enhancing biological weaponry be made available to future national or terrorist BW programs? This presentation will explain why these questions are difficult to answer but nevertheless will propose answers to them. The authors have a basis for doing so because they have been able to collect and analyze information from primary resources in archives and special collections, as well as in the course of hundreds of hours spent on interviewing scientists who operated the Soviet BW program. During his presentation, Zilinskas will discuss tentative findings that encompass subjects such as whether the application of genetic engineering, which resulted in among other accomplishments the development of multiantibiotic resistant Bacillus anthracis, Francisella tularensis, and Yersinia pestis, actually resulted in improved weaponry and whether genetically engineered strains remain in Russian cell culture collections and from there might escape or be made available to those who seek to acquire biological weapons.

About the speaker: Raymond A. Zilinskas, formerly a clinical microbiologist, is the director of the Chemical and Biological Weapons Nonproliferation Program at the Center for Nonproliferation Studies of the Monterey Institute of International Studies. He is the editor of Biological Warfare: Modern Offense and Defense (Lynne Rienner, 1999) and co-editor of the Encyclopedia of Bioterrorism Defense (Wiley, 2005). He received a PhD from the University of Southern California and a BA in Biology from the University of Stockholm.

Karl Eikenberry is the Payne Distinguished Lecturer at the Freeman Spogli Institute for International Studies. Within FSI he is an affiliated faculty member with the Center on Democracy, Development, and the Rule of Law (CDDRL) and the Center for International Security and Cooperation (CISAC), and an affiliated researcher with the Europe Center. Before coming to Stanford, he served as U.S. Ambassador to Afghanistan from May 2009 to July 2011, where he led the civilian side of the surge directed by President Obama to reverse Taliban momentum and help set the conditions for transition to full Afghan sovereignty.

Prior to his appointment as Chief of Mission in Kabul, Ambassador Eikenberry had a 35-year career with the U.S. Army, retiring with the rank of Lieutenant General in 2009.  His operational posts include service in the continental U.S., Hawaii, Korea, Italy, and Afghanistan, where he served as Commander of the American-led Coalition Forces from 2005-2007.

Ambassador Eikenberry also served in various political-military positions, including service as Deputy Chairman of the North Atlantic Treaty Organization (NATO) Military Committee in Brussels.

His military awards include the Defense Distinguished and Superior Service Medals, Legion of Merit, Bronze Star, Ranger Tab, Combat and Expert Infantryman badges, and master parachutist wings. He has received numerous civilian awards as well.

Amb. Eikenberry is a graduate of the U.S. Military Academy, holds master's degrees from Harvard University in East Asian Studies and Stanford University in Political Science, and was a National Security Fellow at the Kennedy School of Government at Harvard.

He is a trustee of the International Institute for Strategic Studies and a member of the Council on Foreign Relations and the Council of American Ambassadors. He recently received the George F. Kennan Award for Distinguished Public Service from the National Committee on American Foreign Policy. He has published numerous articles on U.S. military training, tactics, and strategy and on Chinese military history and Asia-Pacific security issues.